Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Time to Buy?

Ono Pharmaceutical Co. (OTCMKTS:OPHLF) shares gapped up prior to trading on Friday . The stock had previously closed at $13.38, but opened at $15.33. Ono Pharmaceutical shares last traded at $14.61, with a volume of 911 shares trading hands.

Analysts Set New Price Targets

Separately, Zacks Research raised Ono Pharmaceutical from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat, Ono Pharmaceutical currently has an average rating of “Strong Buy”.

Ono Pharmaceutical Stock Performance

The company has a quick ratio of 2.56, a current ratio of 3.02 and a debt-to-equity ratio of 0.10. The stock has a 50 day simple moving average of $14.32 and a two-hundred day simple moving average of $14.73. The stock has a market capitalization of $6.87 billion, a P/E ratio of 14.76 and a beta of 0.34.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research?based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.